K. Kleber

669 citations
8 papers · 531 · h-index 5

Impact in

  • Hepatology top 2%
    • Hepatitis C virus research
    • Hepatitis Viruses Studies and Epidemiology
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Hepatitis B Virus Studies
    • Liver Disease Diagnosis and Treatment

Papers in

K. Kleber

8 papers receiving 517 citations

Peers

K. Kleber
Comparison fields: 5 of 27
  • Hepatology 513
  • Epidemiology 513
  • Infectious Diseases 129
  • Virology 3
  • Immunology 11
Replace S. Xiong with:
S. Xiong China
A.R. Türkyilmaz Türkiye
Beatriz Calle Serrano Germany
Cecilia Marrocco Italy
Karl‐Georg Simon Germany
K. Klesczewski United States
Guangbi Yao China
A. Guastadisegni Italy
Annika Kau Germany
Rie Mineta Japan
K. Kleber relative to S. Xiong China S. Xiong's profile →
Citations per field
00.5×1.6×
S. Xiong · 1×
Citations per year

Countries citing papers authored by K. Kleber

Since Specialization
Citations

This map shows the geographic impact of K. Kleber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Kleber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Kleber more than expected).

Fields of papers citing papers by K. Kleber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Kleber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Kleber. The network helps show where K. Kleber may publish in the future.

Co-authors

The 25 scholars most cited alongside K. Kleber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with K. Kleber Line = papers co-authored together K. Kleber links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B 1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary’s Hospital, London, England); C. Trepo (Hopital Hôtel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ).
2003440
2 200634
3 200726
4 200221
5 20034
6 20044
7 20031
8 20041

About K. Kleber

K. Kleber is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Immunology and Genetics, having authored 8 papers that have together received 531 indexed citations. Recurring topics across this work include Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (6 papers), HIV/AIDS drug development and treatment (5 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Hepatology (513 citations), Epidemiology (513 citations), Infectious Diseases (129 citations), Virology (3 citations) and Immunology (11 citations). K. Kleber has collaborated with scholars based in United States, Germany and Tunisia. Frequent co-authors include Carol Brosgart, Marion G. Peters, Peter Buggisch, Mark Sullivan, Paul Martin, Ramin Ebrahimi, Christian Trépo, S. Xiong, R Rubin and Hie‐Won Hann. Their work appears in journals such as Journal of Hepatology, Gastroenterology and Journal of Pediatric Gastroenterology and Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact